meRfi®-GM
Probiotics (living agents) & Irritable Bowel Syndrome (IBS)
Welcome to meRfi-GM!
meRfi-GM provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.
Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.
Start your free trial and transform your understanding of the gut microbiota today!
Navigation
Contents
Based on fifty-three RCTs of probiotics involving 5545 patients, particular combinations of probiotics or specific species and strains appeared to affect global Irritable Bowel Syndrome (IBS) symptoms and abdominal pain positively. Still, it was impossible to draw definitive conclusions about their efficacy
According to World Gastroenterology Organization, some probiotic strains may reduce pain and provide global relief in IBS with a consistent reduction of abdominal bloating and flatulence in publi…
References (Sources)
- Clinical trial: Probiotic treatment of acute distal ulcerative colitis with rectally administered Escherichia coli Nissle 1917 (EcN)
- Effect of probiotic supplementation on schizophrenia symptoms and association with gastrointestinal functioning: a randomized, placebo-controlled trial
- Effects of multispecies probiotic supplementation on intestinal microbiota in irritable bowel syndrome
- Efficacy and safety profile of LCR35 complete freeze-dried culture in irritable bowel syndrome: a randomized, double-blind study
- Probiotic supplementation improves inflammatory status in patients with rheumatoid arthritis
- Probiotics and gastrointestinal diseasesReview
- Treatment of irritable bowel syndrome with Escherichia coli strain Nissle 1917 (EcN): A retrospective survey